Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys

Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34-56-Specific Cytotoxic T Cells

(2014) Y. S. Kap et al.   JOURNAL OF IMMUNOLOGY

Treatment of multiple sclerosis with Anti-CD20 antibodies

(2011) Barbara Barun et al.   CLINICAL IMMUNOLOGY

Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56peptide in incomplete adjuvant

(2011) S. Anwar Jagessar et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Ustekinumab for the treatment of psoriasis

(2011) Philip M Laws et al.   Expert Review of Clinical Immunology

Discrepant Effects of Human Interferon-gamma on Clinical and Immunological Disease Parameters in a Novel Marmoset Model for Multiple Sclerosis

(2011) S. Anwar Jagessar et al.   Journal of Neuroimmune Pharmacology

B-Cell Depletion Attenuates White and Gray Matter Pathology in Marmoset Experimental Autoimmune Encephalomyelitis

(2011) Yolanda S. Kap et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Breaking Free of Sample Size Dogma to Perform Innovative Translational Research

(2011) P. Bacchetti et al.   Science Translational Medicine

EAE: imperfect but useful models of multiple sclerosis

(2011) Bert A. ’t Hart et al.   TRENDS IN MOLECULAR MEDICINE

Late B Cell Depletion with a Human Anti-Human CD20 IgG1  Monoclonal Antibody Halts the Development of Experimental Autoimmune Encephalomyelitis in Marmosets

(2010) Y. S. Kap et al.   JOURNAL OF IMMUNOLOGY

Induction of Progressive Demyelinating Autoimmune Encephalomyelitis in Common Marmoset Monkeys Using MOG34-56Peptide in Incomplete Freund Adjuvant

(2010) S. Anwar Jagessar et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

BAFF: a local and systemic target in autoimmune diseases

(2009) I. Moisini et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Identification of BLyS (B Lymphocyte Stimulator), a Non-Myelin-Associated Protein, as a Functional Ligand for Nogo-66 Receptor

(2009) L. Zhang et al.   JOURNAL OF NEUROSCIENCE

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

(2009) Kenneth R Carson et al.   LANCET ONCOLOGY

Autoimmunity Against Myelin Oligodendrocyte Glycoprotein Is Dispensable for the Initiation Although Essential for the Progression of Chronic Encephalomyelitis in Common Marmosets

(2008) S. Anwar Jagessar et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

(2008) Benjamin M Segal et al.   LANCET NEUROLOGY

Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary

(2008) Rocio S. Lopez-Diego et al.   NATURE REVIEWS DRUG DISCOVERY

BAFF, APRIL, TWE-PRIL: Who's who?

(2007) Capucine Daridon et al.   AUTOIMMUNITY REVIEWS